The active cases further declined to 6,43,194 comprising 2.14 per cent of the total infections
India's total tally of COVID-19 cases crossed the three crore mark with one crore infections being added in 50 days.
The total tally mounted to 3,00,28,709 with 50,848 new coronavirus infections being reported in a day, while the death count climbed to 3,90,660 with 1,358 fresh fatalities, according to the Union Health Ministry data updated on Wednesday.
India's total COVID-19 infections had surpassed the one crore mark on December 19 after which it took around 136 days to cross the two crore mark on May 4.
The active cases further declined to 6,43,194 comprising 2.14 per cent of the total infections, while the national COVID-19 recovery rate has improved to 96.56 per cent.
Meanwhile, amid worries of a possible third Covid wave, along with the emergence of a Delta Plus variant in parts of the country, one of India's top doctors and genome sequencer has brushed aside concerns of this new mutant fuelling an upsurge in infections. Dr Anurag Agarwal, Director of the Institute of Genomics and Integrative Biology (IGIB), also advised caution against lowering the guard on the second wave itself.
Here are the updates on coronavirus (COVID-19) cases:
In two-to-three months from now, experts in India will know if Bharat Biotech's Covaxin works on children as young as two. The process of testing the vaccine's efficacy against Covid has begun, Dr Randeep Guleria, Director of the All-India Institute of Medical Sciences (AIIMS) Delhi, has said.
"Bharat Biotech is looking at vaccinating children of 2 years to 18 years. It has already started...a number of children have already been vaccinated," Dr Guleria told NDTV.
"Over the next 2-3 months we should be able to say whether these vaccines work in children even as young as two years old. And then they should get regulatory approval. Pfizer already has the regulatory approval but for a little older age group," he said.
Amid worries of a possible third Covid wave, along with the emergence of a Delta Plus variant in parts of the country, one of India's top doctors and genome sequencer has brushed aside concerns of this new mutant fuelling an upsurge in infections. Dr Anurag Agarwal, Director of the Institute of Genomics and Integrative Biology (IGIB), also advised caution against lowering the guard on the second wave itself.
"At this point, there is no evidence to suggest that Delta Plus...has anything to do with a possible third wave," Dr Agarwal told NDTV.
As Telangana lifts COVID-19 restrictions and reopens classes for educational institutes, universities in Hyderabad have stepped up the vaccination of students, non-teaching staff and faculty.
Colleges are gearing up to welcome students back to classrooms after several months of online classes and vaccination drives have been initiated to sure the safest environment for all those present on campuses.
In order to ensure that health is not compromised, colleges have also extended this service to family members and people who are not associated with the colleges.
